Opening Keynote Presentation
Endo- and Exoproteolytic Removal of Affinity Tags
David S. Waugh, Ph.D., Chief, Protein Engineering Section, Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick
Talk Title to be Announced
Ian Hunt, Ph.D., Associate Director, Protein Structure Group, Discovery Technologies, Novartis Institutes for BioMedical Research
Solutions for the Expression and Purification of Pre-Clinical Grade Therapeutic Proteins
Richard J. Buick, Ph.D., Technical Director, Fusion Antibodies, Ltd.
Purifying Membrane Proteins
Lawrence DeLucas, Ph.D., Director, Center for Biophysical Sciences & Engineering, University of Alabama, Birmingham
Self-Cleaving Tags: New Options and New Applications
David W. Wood, Associate Professor, Chemical & Biomolecular Engineering, The Ohio State University
The Biotinylated Sortase Self-Cleavage Purification Method (BISOP) Combined with the Wheat Germ Cell-Free System
Yaeta Endo, Ph.D., Professor & Director, Cell-Free Science and Technology Research Center, Ehime University, Matsuyama, Japan
PEGylate and Purify: A Dual Role of His-tag for PEGylated Therapeutics
Ji-won Choi, Ph.D., Director, Biology, PolyTherics, Ltd.
Using Tandem Affinity Purification-Mass Spectrometry for Analyzing Intracellular Signaling Complexes
Alexey Veraksa, Ph.D., Assistant Professor, Biology, College of Science & Mathematics, University of Massachusetts, Boston
Lessons Learned (and Learning) When Increasing Throughput
William Gillette, Ph.D., Senior Scientist, Protein Expression Laboratory, SAIC-Frederick, Inc.
Progress in Production and Biospecific Separation of Proteins
Sophia Hober, Ph.D., Professor, Proteomics, KTH Biotechnology, Royal Institute of Technology, Stockholm, Sweden
Sponsored Presentation
